Elsevier’s world leading preprint server and early stage research platform has announced the launch of "Preprints with The Lancet"—a new preprint series for sharing early stage health and medical research
Together, the companies will leverage expertise in genomics and molecular information to enhance the development of personalized medicines and care for patients with cancer